文献速递膀胱癌与上尿路尿路上皮癌

种族与性别对转移性膀胱癌生存的影响

The Impact of Race and Sex on Metastatic Bladder Cancer Survival.
PubMed 文献 · Urology · 2021-11-20

基于监测、流行病学和最终结果计划(SEER)数据库(2000-2017年)分析312846例膀胱癌患者,评估种族与性别组合对转移性膀胱癌生存的影响。黑人女性在转移性移行细胞癌、鳞状细胞癌和腺癌中的癌症特异性生存率分别为4.3%、2.6%和6.4%,在区域转移性疾病中黑人女性的癌症特异性死亡风险更高(aHR 1.17,P=0.023)。

要点

  • 黑人女性转移性移行细胞癌癌症特异性生存率为4.3%(95%CI:1.6-8.9)。
  • 黑人女性转移性鳞状细胞癌癌症特异性生存率为2.6%(95%CI:0.2-11.8)。
  • 区域转移性疾病中黑人女性癌症特异性死亡风险aHR 1.17(P=0.023)。

核心结论

  • 黑人女性在转移性膀胱癌的总体和肿瘤学结局中经历超额死亡。
  • 研究结果支持需要检查健康社会决定因素和提供者决策对膀胱癌生存的影响,并有助于医生在膀胱癌治疗和监测中的决策。

研究设计与样本

  • 查询监测、流行病学和最终结果计划(SEER)数据库(2000-2017年)中所有就诊时即为转移性膀胱癌的患者。
  • 共评估312846例膀胱癌患者,其中6337例为远处转移,11446例为区域转移。
  • 主要暴露变量为四种种族/性别组合。
  • 采用单因素方差分析和卡方检验比较分类变量和连续变量。
  • 采用单变量和多变量Cox比例风险回归分析检查种族/性别组合与总生存和癌症特异性生存之间的关联,并调整其他变量。

主要发现

  • 黑人女性转移性移行细胞癌的癌症特异性生存率为4.3%(95%CI:1.6-8.9)。
  • 黑人女性转移性鳞状细胞癌的癌症特异性生存率为2.6%(95%CI:0.2-11.8)。
  • 黑人女性转移性腺癌的癌症特异性生存率为6.4%(95%CI:0.4%-25%)。
  • 在区域转移性疾病中,较差的癌症特异性死亡与黑人女性(aHR 1.17,P=0.023)、鳞状细胞癌(aHR 1.8,P<0.001)、年龄增加(aHR 1.3,P<0.001)和低分化分级(aHR 2.01,P<0.001)相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize the epidemiological profile of metastatic bladder cancer (BC) and assess mortality rate with respect to race and gender across the three most common histologies of bladder cancer-Transitional Cell Carcinoma, Adenocarcinoma, and SCC (Squamous Cell Carcinoma). MATERIALS AND METHODS: The Surveillance, Epidemiology, and End Results Program database (2000-2017) was queried for all metastatic bladder cancer patients at presentation. Our primary exposure consists of four race/gender combinations. One-way ANOVA and Chi-square tests compared categorical and continuous variables across the exposure variable, respectively. Univariable and multivariable Cox proportional hazards regression analyses were used to examine the association between race/gender combinations and the overall and cancer specific survival adjusting for the other variables. RESULTS: A total of 312,846 bladder cancer patients, 6337 with distant metastases and 11,446 with regional metastases were evaluated. Black female cancer specific survival in metastatic disease was disproportionally lower compared to all race/gender for Transitional Cell Carcinoma 4.3% (95% CI: 1.6-8.9), SCC 2.6% (95% CI: 0.2-11.8), and Adenocarcinoma 6.4% (0.4%-25%). In regional metastastatic disease, worse cancer specific mortality was associated with identifying as a Black Female (aHR 1.17, P = .023), SCC (aHR 1.8, P <.001), increasing age (aHR 1.3, P <.001), and poorly differentiated grade (aHR 2.01, P <.001). CONCLUSION: Black females experience excess mortality in overall and cancer oncologic outcomes in metastatic BC. Our findings contribute to the body of research warranting examination of the impact of social determinants of health and provider decisions on BC survivorship and contribute to physician decision making in the treatment and surveillance of bladder cancer.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Mahran A, Miller A, Calaway A, et al. The Impact of Race and Sex on Metastatic Bladder Cancer Survival. Urology. 2021. PMID: 34813833. doi:10.1016/j.urology.2021.08.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。